To investigate a possible function of Oct4 expression in somatic cells we used a Cre-lox based recombination approach to achieve tissue-specific inactivation of a conditional Oct4 allele ( Oct4-2lox, Fig 1a) ( Kehler et al., 2004). Oct4-2lox mice were crossed to mice carrying tissue specific or inducible Cre transgenes to inactivate Oct4 in organs that have a well-defined somatic stem cell population. We deleted Oct4 in the intestine, bone marrow, brain, liver and hair follicles since Oct4 expression has previously been documented in these tissues ( Table S1). The Cre transgenes that were used to achieve cell-type specific deletion of Oct4 in these tissues are described in Table 1. | Figure 1 Regeneration of the Intestinal Epithelium after Villin-CreER Mediated Oct4 Inactivation |
Intestinal Epithelium Inactivation of Oct4 in the intestinal epithelium (including progenitor cells residing in the intestinal crypt) was achieved through the tamoxifen-induced activation of a transgene encoding a Cre recombinase/estrogen receptor fusion protein under transcriptional control of the Villin promoter ( Villin-CreER) (el Marjou et al., 2004) in 8-week old mice. Recombination of the Oct4-2lox allele was confirmed by Southern Blot analysis (data not shown). Weight gain was monitored in adult mice for a period of nine months with no differences observed between control ( Oct4 1lox/+, transgenic) and Oct4 mutant ( Oct4 1lox/1lox, transgenic) mice ( Fig S1). Histological analysis revealed a normal tissue architecture containing differentiated cell types (Paneth and goblet cells), a normal distribution of proliferating cells marked by Ki67 expression , and an absence of any Oct4 positive cells in the crypts ( Fig S1). In order to test the regenerative capacity of intestinal crypt progenitor cells in the absence of Oct4, mice were subjected to a 14 Gy dose of γ-irradiation. This resulted in widespread apoptosis and cell death coupled with a growth arrest within three days. Five days after γ-irradiation, intestinal progenitor cells became highly proliferative in the presence or absence of Oct4, giving rise to new crypts that re-established a normal intestinal epithelium by the eighth day after irradiation ( Fig 1c–e). In order to exclude the possibility that a small number of progenitor cells escaped recombination and were responsible for the observed regeneration and maintenance of the intestinal epithelium, we performed PCR analysis of the Oct4 genomic locus. This analysis revealed no evidence of non-recombined Oct4- 2lox alleles in the newly generated tissue ( Fig 1f). Finally we examined Oct4 gene expression throughout the time course of epithelial recovery after irradiation and found little to no Oct4 mRNA. Oct4 expression in the intestine was found to be 10 5 times lower in comparison to ES cells ( Fig 1g). Further purification of crypt progenitor cells by EDTA-based fractionation of intestinal epithelium followed by gene expression analysis revealed no preference for Oct4 expression at the base of the crypt ( Fig S1). These findings indicate that Oct4 function is not required for maintenance of the intestinal stem cell niche. Mesenchymal Stem Cells In order to examine the effects of Oct4 deletion in the bone marrow we employed an interferon-inducible Mx1-Cre transgene ( Table 1) ( Kuhn et al., 1995; Schneider et al., 2003). We confirmed that activation of Mx1-Cre resulted in 100% recombination in the whole marrow by PCR analysis ( Fig. 2a). Subsequent separation of mesenchymal and hematopoietic cells confirmed recombination in both cell lineages (Data not shown). MSCs known to give rise to cells of chondrogenic, adipogenic, myogenic, and osteogenic lineages ( Keating, 2006) were derived from both control and mutant bone marrow. These cells, as well as multipotent subpopulations of MSCs, have been the most frequently cited source of Oct4 expression in somatic tissues ( Table S1). The proliferative capacity and potential for lineage commitment of MSCs was addressed using in vitro colony formation assays, osteoblast and chondrocyte differentiation assays. Individual MSCs derived from both control and Oct4 mutant MSCs were able to proliferate to form clonal colonies ( Fig. 2b). Upon reaching confluence, these cells underwent osteogenic differentiation in the presence of ascorbic acid and inorganic phosphate, forming multilayered nodules containing mineralized extracellular matrix- hallmarks of mature osteoblasts ( Fig. 2d). No Oct4 positive cells were observed during colony formation ( Figure 2c) Gene expression analysis throughout the time course of osteogenic lineage commitment revealed no significant Oct4 gene activity in whole marrow, proliferating MSCs or in differentiated osteoblasts ( Fig. 2e). Similarly, Oct4 mutant MSCs were able to activate Sox9 gene expression and enter the chondrogenic lineage in BMP treated micromass cultures ( Fig. 2f & Fig. S2). | Figure 2 Proliferative and Lineage Commitment Capacity of Bone Marrow-derived MSCs after Mx1-Cre Mediated Inactivation of Oct4 |
Hematopoietic Lineages Oct4 function was addressed in the well-defined hematopoietic stem cell ( Kondo et al., 2003). Examination of the peripheral blood circulation of control and Oct4 mutant mice 5, 12, and 35 days after Mx1-Cre induced recombination revealed no deficiency in the ability of Oct4 mutant mice to maintain white blood cell (WBC), red blood cell (RBC) or platelet counts at control levels throughout the experiment ( Fig. 3a&b). Flow cytometric analysis of the bone marrow for monocyte, B-cell, and granulocyte lineages at 12 and 35 days after recombination showed little difference in the representation of these cell types between control and Oct4 mutant animals ( Fig. 3c and not shown). Furthermore, Oct4 deletion did not affect the lineage negative , c-kit+, sca1+ population of HSCs in the bone marrow ( Fig. 3d) ( Camargo et al., 2006). Subsequent analysis of Flt3 negative long-term HSCS and Flt3 positive short-term HSCs showed no variation in these populations in the absence of Oct4 (not shown). Quantitative RT-PCR analysis of flow-sorted HSCs, common lyphoid progenitors, granulocytes, and monocytes revealed no preference for Oct4 expression in stem cells, and expression in all of these cell types was negligible in comparison to ES cells ( Fig S2). PCR analysis for the 2-lox and recombined 1-lox Oct4 alleles 8 weeks after Mx1-Cre activation verified the persistence of Oct4 null cells in the marrow ruling out potential functional contribution of any cells escaping Cre-mediated recombination ( Fig 3e). Ultimately, we tested the regenerative potential of the HSCs by performing a competitive reconstitution assay in which equal numbers of either control or Oct4 mutant marrow cells bearing a CD45.1 cell surface antigen were isolated 5 days after Mx1-Cre activation and co-injected along with CD45.2 competitor cells into lethally irradiated recipient mice. The CD45.1 and CD45.2 cells were allowed to compete for re-establishment of the recipient’s hematopoietic system and the relative contribution of each donor cell was assessed ( Fig 3f). We found no significant differences in the ability of control or Oct4 mutant cells to repopulate the ablated hematopoietic systems of recipient animals. Moreover, the observed reconstitution was stable over time demonstrating that HSCs lacking functional Oct4 alleles fully retain long-term pluripotency. | Figure 3 Hematopoietic Lineage Analysis in Mx1-Cre, Oct4 Conditional Mice |
Liver While a clearly defined stem cell niche has not been identified in the liver, several candidate progenitor cells have been described ( Walkup and Gerber, 2006) and Oct4 has been observed in liver derived stem cells ( Beltrami et al., 2007). To test whether Oct4 functions in liver regeneration, we performed partial hepatectomies after inactivation of Oct4 using Mx1-Cre ( Kuhn et al., 1995; Schneider et al., 2003) ( Fig. 4a). Two months after removal of 75% of the liver, both control and Oct4 mutant mice were able to fully regenerate lost tissue. The newly generated liver was histologically normal, containing mature hepatocytes, bile ducts, and vascularization ( Fig. 4b). In addition, Oct4 protein was undetectable by immunostaining and little to no Oct4 mRNA was expressed in the regenerated liver ( Fig. 4c&d). As in the intestinal epithelium, the newly regenerated liver of Oct4 mutant mice lacked non-recombined Oct4-2lox alleles ( Fig 4e), demonstrating that cells lacking functional Oct4 alleles are capable of tissue regeneration. | Figure 4 Liver Regeneration after Mx1-Cre Mediated Inactivation of Oct4 |
Brain The Oct4 zebrafish ortholog spiel ohne grenzen (spg) has been shown to be necessary for formation of the mid- and hindbrain ( Belting et al., 2001) and cultures of mammalian neural progenitors exhibit Oct4 expression ( Davis et al., 2006; Okuda et al., 2004). We therefore examined the effect of Oct4 deletion in neural progenitor cells. A paternally transmitted Nestin-Cre transgene was used to excise the Oct4 conditional allele in all neural progenitor cells of the developing brain ( Table 1)( Bates et al., 1999; Fan et al., 2001). Oct4 mutant mice exhibited no apparent behavioral abnormalities and brain morphology appeared normal more than one year after Oct4 deletion ( Fig. 5a). Ki67-positive neural stem cells were seen in the subventricular zone of the lateral ventricles of both control and Oct4 mutant mice ( Fig 5a&b). Oct4 expression in this region was undetectable by immunostaining ( Fig 5a&b), and Oct4 mRNA nearly undetectable in both control and mutant brain extract, embryonic day 13 brain extract, as well as in purified primary cultures of neural progenitor cells ( Fig 5c). | Figure 5 CNS Analysis in Oct4 conditional, Nestin-Cre mice and Hair Follicle Analysis in Oct4 conditional, K15-CrePr1 mice |
Hair Follicle The function of Oct4 was examined in the hair follicle through activation of a Keratin1-15 CrePr1 transgene ( K15-CrePr1). This transgene encodes a Cre-progesterone receptor fusion protein and is expressed exclusively in the hair follicle bulge stem cells ( Morris et al., 2004). These cells give rise to all differentiated cell types in the follicle, enter the dermal lineage during wound healing ( Ito et al., 2005) and have previously been shown to express Oct4 ( Yu et al., 2006). The hair follicles of 8-week old mice were examined after activation of K15-CrePr1 through dermal administration of the progesterone antagonist mifepristone. We observed differentiated cell types and sebaceous glands in both control and Oct4 mutant follicles ( Fig. 5d). Immunostaining with Oct4 and Ki67 antibodies revealed no Oct4 positive cells in or around the follicle and a normal distribution of proliferating cells ( Fig. 5d), and qRT-PCR analysis of mRNA isolated from skin revealed no significant Oct4 expression relative to ES cells ( Fig 4d). To test the regenerative capacity of the skin in control and Oct4 mutant mice, we performed wound-healing assays in which 8 mm, full-thickness dermal biopsies were monitored for 2 weeks and found no significant differences in wound-healing capacity ( Fig. 5e). While recent studies have demonstrated that an additional epidermal stem cell, which may or may not have inactivated Oct4 in our model, can contribute to wound healing and follicle formation after wounding, our Oct4 K15-CrePr1 mice were able to continue hair growth during homeostatic conditions, a process known to be dependent on the K15-positive stem cells of the follicular bulge ( Morris et al., 2004). Oct4 Expression in Somatic Cells The results described thus far failed to reveal any functional role for Oct4 in the homeostasis or regeneration of a number of somatic tissues. Because Oct4 expression in somatic tissues has been detected in stem cell populations by PCR or immuno-histological methods in a number of published reports ( Table S1), we attempted to confirm these observations using another approach. We generated a reporter allele through homologous recombination in ES cells in which EGFP is expressed from the endogenous Oct4 locus ( Oct4-EGFP) ( Fig 1b). The fidelity of the reporter was confirmed by flow cytometric analysis of targeted ES cells. Over 95% of Oct4-EGFP ES cells strongly expressed EGFP, consistent with their pluripotent state ( Fig 6a). We subsequently generated mice from Oct4-EGFP ES cells and examined EGFP expression at the single cell level in a number of tissues. Flow cytometric analysis of whole bone marrow containing multipotent MSCs and HSCs revealed no EGFP positive cell population when compared to wildtype marrow ( Fig 6b). Purification of c-kit+, sca1+, lineage- HSCs derived from the bone marrow confirmed the absence of Oct4 expressing hematopoietic progenitors ( Fig 6c). In addition to the bone marrow, numerous other tissues, including liver, brain, intestine, stomach, skeletal muscle, skin, lungs, heart, spleen, kidney, bladder, thymus, and prostate were examined using antibodies raised against EGFP and positive signals were never observed in contrast to teratomas derived from Oct4-EGFP ES cells, which exhibit pockets of undifferentiated cells with strong GFP expression ( Fig S3 and data not shown). These findings, coupled with the failure to detect Oct4 transcripts by qRT-PCR, indicate that the endogenous Oct4 locus is inactive in the adult mouse. Our results are consistent with the Oct4 locus being effectively silenced in somatic tissues and therefore dispensable for the maintenance of somatic stem cells or tissue regeneration in the adult. | Figure 6 Oct4 Gene Expression in Bone Marrow and HSCs |
|
References - Bates, B; Rios, M; Trumpp, A; Chen, C; Fan, G; Bishop, JM; Jaenisch, R. Neurotrophin-3 is required for proper cerebellar development. Nat Neurosci. 1999;2:115–117. [PubMed]
- Belting, HG; Hauptmann, G; Meyer, D; Abdelilah-Seyfried, S; Chitnis, A; Eschbach, C; Soll, I; Thisse, C; Thisse, B; Artinger, KB, et al. spiel ohne grenzen/pou2 is required during establishment of the zebrafish midbrain-hindbrain boundary organizer. Development. 2001;128:4165–4176. [PubMed]
- Beltrami, AP; Cesselli, D; Bergamin, N; Marcon, P; Rigo, S; Puppato, E; D’Aurizio, F; Verardo, R; Piazza, S; Pignatelli, A, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow). Blood. 2007
- Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JP; Guenther, MG; Kumar, RM; Murray, HL; Jenner, RG, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122:947–956. [PubMed]
- Camargo, FD; Chambers, SM; Drew, E; McNagny, KM; Goodell, MA. Hematopoietic stem cells do not engraft with absolute efficiencies. Blood. 2006;107:501–507. [PubMed]
- Cervello, I; Martinez-Conejero, JA; Horcajadas, JA; Pellicer, A; Simon, C. Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Hum Reprod. 2006
- Davis, SF; Hood, J; Thomas, A; Bunnell, BA. Isolation of adult rhesus neural stem and progenitor cells and differentiation into immature oligodendrocytes. Stem Cells Dev. 2006;15:191–199. [PubMed]
- D’Ippolito, G; Diabira, S; Howard, GA; Menei, P; Roos, BA; Schiller, PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci. 2004;117:2971–2981. [PubMed]
- D’Ippolito, G; Diabira, S; Howard, GA; Roos, BA; Schiller, PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone. 2006;39:513–522. [PubMed]
- Dyce, PW; Wen, L; Li, J. In vitro germline potential of stem cells derived from fetal porcine skin. Nat Cell Biol. 2006;8:384–390. [PubMed]
- Dyce, PW; Zhu, H; Craig, J; Li, J. Stem cells with multilineage potential derived from porcine skin. Biochem Biophys Res Commun. 2004;316:651–658. [PubMed]
- el Marjou, F; Janssen, KP; Chang, BH; Li, M; Hindie, V; Chan, L; Louvard, D; Chambon, P; Metzger, D; Robine, S. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–193. [PubMed]
- Fan, G; Beard, C; Chen, RZ; Csankovszki, G; Sun, Y; Siniaia, M; Biniszkiewicz, D; Bates, B; Lee, PP; Kuhn, R, et al. DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J Neurosci. 2001;21:788–797. [PubMed]
- Feldman, N; Gerson, A; Fang, J; Li, E; Zhang, Y; Shinkai, Y; Cedar, H; Bergman, Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol. 2006;8:188–194. [PubMed]
- Ferraris, RP; Villenas, SA; Diamond, J. Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. Am J Physiol. 1992;262:G1047–1059. [PubMed]
- Gidekel, S; Pizov, G; Bergman, Y; Pikarsky, E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4:361–370. [PubMed]
- Goolsby, J; Marty, MC; Heletz, D; Chiappelli, J; Tashko, G; Yarnell, D; Fishman, PS; Dhib-Jalbut, S; Bever, CT, Jr; Pessac, B; Trisler, D. Hematopoietic progenitors express neural genes. Proc Natl Acad Sci U S A. 2003;100:14926–14931. [PubMed]
- Gritti, A; Galli, R; Vescovi, AL. Cultures of Stem Cells from the Central Nervous System. In: Fedoroff S, Richardson A. , editors. Protocols for Neural Cell Culture. Totowa, NJ: Humana Press; 2001. pp. 173–185.
- Gupta, S; Verfaillie, C; Chmielewski, D; Kren, S; Eidman, K; Connaire, J; Heremans, Y; Lund, T; Blackstad, M; Jiang, Y, et al. Isolation and Characterization of Kidney-Derived Stem Cells. J Am Soc Nephrol. 2006
- Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 2005;121:465–477. [PubMed]
- Ito, M; Liu, Y; Yang, Z; Nguyen, J; Liang, F; Morris, RJ; Cotsarelis, G. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005;11:1351–1354. [PubMed]
- Izadpanah, R; Trygg, C; Patel, B; Kriedt, C; Dufour, J; Gimble, JM; Bunnell, BA. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006
- Jiang, Y; Jahagirdar, BN; Reinhardt, RL; Schwartz, RE; Keene, CD; Ortiz-Gonzalez, XR; Reyes, M; Lenvik, T; Lund, T; Blackstad, M, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49. [PubMed]
- Johnson, J; Bagley, J; Skaznik-Wikiel, M; Lee, HJ; Adams, GB; Niikura, Y; Tschudy, KS; Tilly, JC; Cortes, ML; Forkert, R, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122:303–315. [PubMed]
- Keating, A. Mesenchymal stromal cells. Curr Opin Hematol. 2006;13:419–425. [PubMed]
- Kehler, J; Tolkunova, E; Koschorz, B; Pesce, M; Gentile, L; Boiani, M; Lomeli, H; Nagy, A; McLaughlin, KJ; Scholer, HR; Tomilin, A. Oct4 is required for primordial germ cell survival. EMBO Rep. 2004;5:1078–1083. [PubMed]
- Kondo, M; Wagers, AJ; Manz, MG; Prohaska, SS; Scherer, DC; Beilhack, GF; Shizuru, JA; Weissman, IL. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003;21:759–806. [PubMed]
- Kues, WA; Petersen, B; Mysegades, W; Carnwath, JW; Niemann, H. Isolation of murine and porcine fetal stem cells from somatic tissue. Biol Reprod. 2005;72:1020–1028. [PubMed]
- Kuhn, R; Schwenk, F; Aguet, M; Rajewsky, K. Inducible gene targeting in mice. Science. 1995;269:1427–1429. [PubMed]
- Lamoury, FM; Croitoru-Lamoury, J; Brew, BJ. Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1. Cytotherapy. 2006;8:228–242. [PubMed]
- Lengner, CJ; Lepper, C; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB. Primary mouse embryonic fibroblasts: a model of mesenchymal cartilage formation. J Cell Physiol. 2004;200:327–333. [PubMed]
- Lengner, CJ; Steinman, HA; Gagnon, J; Smith, TW; Henderson, JE; Kream, BE; Stein, GS; Lian, JB; Jones, SN. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol. 2006;172:909–921. [PubMed]
- Ling, TY; Kuo, MD; Li, CL; Yu, AL; Huang, YH; Wu, TJ; Lin, YC; Chen, SH; Yu, J. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A. 2006;103:9530–9535. [PubMed]
- Loh, YH; Wu, Q; Chew, JL; Vega, VB; Zhang, W; Chen, X; Bourque, G; George, J; Leong, B; Liu, J, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006;38:431–440. [PubMed]
- Looijenga, LH; Stoop, H; de Leeuw, HP; de Gouveia Brazao, CA; Gillis, AJ; van Roozendaal, KE; van Zoelen, EJ; Weber, RF; Wolffenbuttel, KP; van Dekken, H, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244–2250. [PubMed]
- Matthai, C; Horvat, R; Noe, M; Nagele, F; Radjabi, A; van Trotsenburg, M; Huber, J; Kolbus, A. Oct-4 expression in human endometrium. Mol Hum Reprod. 2006;12:7–10. [PubMed]
- Mongan, NP; Martin, KM; Gudas, LJ. The putative human stem cell marker, Rex-1 (Zfp42): Structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog. 2006
- Moriscot, C; de Fraipont, F; Richard, MJ; Marchand, M; Savatier, P; Bosco, D; Favrot, M; Benhamou, PY. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells. 2005;23:594–603. [PubMed]
- Morris, RJ; Liu, Y; Marles, L; Yang, Z; Trempus, C; Li, S; Lin, JS; Sawicki, JA; Cotsarelis, G. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol. 2004;22:411–417. [PubMed]
- Nayernia, K; Lee, JH; Drusenheimer, N; Nolte, J; Wulf, G; Dressel, R; Gromoll, J; Engel, W. Derivation of male germ cells from bone marrow stem cells. Lab Invest. 2006;86:654–663. [PubMed]
- Nichols, J; Zevnik, B; Anastassiadis, K; Niwa, H; Klewe-Nebenius, D; Chambers, I; Scholer, H; Smith, A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379–391. [PubMed]
- Okuda, T; Tagawa, K; Qi, ML; Hoshio, M; Ueda, H; Kawano, H; Kanazawa, I; Muramatsu, M; Okazawa, H. Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. Brain Res Mol Brain Res. 2004;132:18–30. [PubMed]
- Owen, TA; Aronow, M; Shalhoub, V; Barone, LM; Wilming, L; Tassinari, MS; Kennedy, MB; Pockwinse, S; Lian, JB; Stein, GS. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 1990;143:420–430. [PubMed]
- Pain, D; Chirn, GW; Strassel, C; Kemp, DM. Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem. 2005;280:6265–6268. [PubMed]
- Pallante, BA; Duignan, I; Okin, D; Chin, A; Bressan, MC; Mikawa, T; Edelberg, JM. Bone marrow Oct3/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms. Circ Res. 2007;100:e1–11. [PubMed]
- Pochampally, RR; Smith, JR; Ylostalo, J; Prockop, DJ. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood. 2004;103:1647–1652. [PubMed]
- Redvers, RP; Li, A; Kaur, P. Side population in adult murine epidermis exhibits phenotypic and functional characteristics of keratinocyte stem cells. Proc Natl Acad Sci U S A. 2006;103:13168–13173. [PubMed]
- Ren, H; Cao, Y; Zhao, Q; Li, J; Zhou, C; Liao, L; Jia, M; Cai, H; Han, ZC; Yang, R, et al. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun. 2006;347:12–21. [PubMed]
- Romagnani, P; Annunziato, F; Liotta, F; Lazzeri, E; Mazzinghi, B; Frosali, F; Cosmi, L; Maggi, L; Lasagni, L; Scheffold, A, et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97:314–322. [PubMed]
- Sagrinati, C; Netti, GS; Mazzinghi, B; Lazzeri, E; Liotta, F; Frosali, F; Ronconi, E; Meini, C; Gacci, M; Squecco, R, et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol. 2006;17:2443–2456. [PubMed]
- Schneider, A; Zhang, Y; Guan, Y; Davis, LS; Breyer, MD. Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am J Physiol Renal Physiol. 2003;284:F411–417. [PubMed]
- Serafini, M; Dylla, SJ; Oki, M; Heremans, Y; Tolar, J; Jiang, Y; Buckley, SM; Pelacho, B; Burns, TC; Frommer, S, et al. Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. J Exp Med. 2007;204:129–139. [PubMed]
- Suo, G; Han, J; Wang, X; Zhang, J; Zhao, Y; Dai, J. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun. 2005;337:1047–1051. [PubMed]
- Tai, MH; Chang, CC; Kiupel, M; Webster, JD; Olson, LK; Trosko, JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005;26:495–502. [PubMed]
- Thomas, T; Nowka, K; Lan, L; Derwahl, M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid. 2006;16:537–544. [PubMed]
- Tondreau, T; Meuleman, N; Delforge, A; Dejeneffe, M; Leroy, R; Massy, M; Mortier, C; Bron, D; Lagneaux, L. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005;23:1105–1112. [PubMed]
- Walkup, MH; Gerber, DA. Hepatic stem cells: in search of. Stem Cells. 2006;24:1833–1840. [PubMed]
- Wang, J; Rao, S; Chu, J; Shen, X; Levasseur, DN; Theunissen, TW; Orkin, SH. A protein interaction network for pluripotency of embryonic stem cells. Nature. 2006;444:364–368. [PubMed]
- Wang, R; Li, J; Yashpal, N. Phenotypic analysis of c-Kit expression in epithelial monolayers derived from postnatal rat pancreatic islets. J Endocrinol. 2004;182:113–122. [PubMed]
- Yamaguchi, S; Yamazaki, Y; Ishikawa, Y; Kawaguchi, N; Mukai, H; Nakamura, T. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosomes Cancer. 2005;43:217–222. [PubMed]
- Yu, H; Fang, D; Kumar, SM; Li, L; Nguyen, TK; Acs, G; Herlyn, M; Xu, X. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol. 2006;168:1879–1888. [PubMed]
- Zhang, S; Jia, Z; Ge, J; Gong, L; Ma, Y; Li, T; Guo, J; Chen, P; Hu, Q; Zhang, P, et al. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant. 2005;14:787–798. [PubMed]
|